Denna sida på svenska
Loading profile information...

Research description

  • Cancer epidemiology
  • Comparative effectiveness and outcomes
  • Evidence-based medicine

Publications

Addition of abiraterone, docetaxel, bisphosphonate, celecoxib or combinations to androgen-deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC): a network meta-analysis
Tan Ps, Aguiar P, Haaland B, Lopes G
PROSTATE CANCER AND PROSTATIC DISEASES 2018;21(4):516-523

A Systematic Review and Meta-Analyses of the Association Between Anti-Hypertensive Classes and the Risk of Falls Among Older Adults
Ang Ht, Lim Kk, Kwan Yh, Tan Ps, Yap Kz, Banu Z, et al
DRUGS & AGING 2018;35(7):625-635

Comparative effectiveness of immune-checkpoint inhibitors for previously treated advanced non-small cell lung cancer - A systematic review and network meta-analysis of 3024 participants
Tan Ps, Aguiar P, Haaland B, Lopes G
LUNG CANCER 2018;:84-88

Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With EGFR-Mutated Advanced Non-Small Cell Lung Cancer
Aguiar Pn, Haaland B, Park W, Tan Ps, Del Giglio A, Lopes Gd
JAMA ONCOLOGY 2018;4(8):1080-1084

Network metanalysis and cost-effectiveness of abiraterone, docetaxel or placebo plus androgen deprivation therapy (ADT) for hormone-sensitive advanced prostate cancer.
Aguiar Pn, Tan Ps, Simko S, Barreto Cmn, Aguiar Bg, Del Giglio A
JOURNAL OF CLINICAL ONCOLOGY 2018;36(15)

Overview of systematic reviews assessing the evidence for shorter versus longer duration antibiotic treatment for bacterial infections in secondary care
Onakpoya Ij, Walker As, Tan Ps, Spencer Ea, Gbinigie Oa, Cook J, et al
PLOS ONE 2018;13(3):e0194858-

Clinician-targeted interventions to influence antibiotic prescribing behaviour for acute respiratory infections in primary care: an overview of systematic reviews
Tonkin-crine Sk, Tan Ps, Van Hecke O, Wang K, Roberts Nw, Mccullough A, et al
The Cochrane database of systematic reviews 2017;9():CD012252-

Meta-analysis of first-line therapies with maintenance regimens for advanced non-small-cell lung cancer (NSCLC) in molecularly and clinically selected populations
Tan Ps, Bilger M, Lopes Gd, Acharyya S, Haaland B
CANCER MEDICINE 2017;6(8):1847-1860

Network meta-analysis comparing first-line therapies and maintenance regimens in EGFR mutated advanced non-small-cell lung cancer (NSCLC).
Lopes G, Tan Ps, Acharyya S, Bilger M, Haaland B
JOURNAL OF CLINICAL ONCOLOGY 2016;34(15)

Ten-year survival in women with primary stage IV breast cancer
Eng Lg, Dawood S, Sopik V, Haaland B, San Tan P, Bhoo-pathy N, et al
BREAST CANCER RESEARCH AND TREATMENT 2016;160(1):145-152

Bayesian Network Meta-Comparison of Maintenance Treatments for Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients
Lopes Gd, Tan Ps, Acharyya S, Bilger M, Haaland B
JOURNAL OF THORACIC ONCOLOGY 2015;10(9):S316-S316

Bayesian network meta-comparison of maintenance treatments for stage IIIb/IV non-small-cell lung cancer (NSCLC) patients with good performance status not progressing after first-line induction chemotherapy: results by performance status, EGFR mutation, histology and response to previous induction
Tan Ps, Lopes G, Acharyya S, Bilger M, Haaland B
European journal of cancer (Oxford, England : 1990) 2015;51(16):2330-44

Overall survival (OS) by EGFR mutation status and subtypes (Deletion 19/L858R) for first-line therapies with maintenance regimens in advanced non-small-cell lung cancer (NSCLC): a Bayesian multiple treatment comparison (MTC) meta-analysis
Tan Ps, Lopes G, Aacharyya S, Bilger M, Haaland B
ANNALS OF ONCOLOGY 2015;:135-135

Childhood drowning in Malaysia
Hss As, San Tan P, Hashim L
INTERNATIONAL JOURNAL OF INJURY CONTROL AND SAFETY PROMOTION 2014;21(1):75-80

Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel-an Indirect Comparison
Tan Ps, Haaland B, Montero Aj, Kyriakopoulos Ce, Lopes G
Clinical Medicine Insights. Oncology 2014;8():29-36

Meta-analysis of first-line therapies in advanced non-small-cell lung cancer harboring EGFR-activating mutations
Haaland B, Tan Ps, De Castro G, Lopes G
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2014;9(6):805-11

A meta-analysis of anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancer
Tan Ps, Haaland B, Montero Aj, Lopes G
BREAST CANCER RESEARCH AND TREATMENT 2013;138(3):961-5

Anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancer: A meta-analysis.
Tan Ps, Haaland B, Montero Aj, Lopes G
JOURNAL OF CLINICAL ONCOLOGY 2013;31(15)

Young age as a good prognostic factor in de novo metastatic breast cancer
Lee Ge, Dawood S, Haaland Ba, Tan Ps, Bhoo-pathy N, Dent Ra
CANCER RESEARCH 2013;

Show all publications

Map

View map

Nobels väg 12A
Stockholm